Ascorbic Acid Articles
Vit C can cut risk of gout; Canadian study
16 March 2009
Data against vit C cancer therapy flawed?
16 March 2009
Beta carotene, vits C and E do not prevent cancer
12 January 2009
Selenium/vit E "do not cut prostate cancer risk"
22 December 2008
Obagi expands partnership with Rohto
22 December 2008
Lack of CV effectiveness for vit E and C in men
17 November 2008
Antioxidant power of kiwi fruit; study
21 July 2008
Tomato anti-carcinogen different to expected
9 June 2008
Fake drugs flood into SE Asia, Thailand expert warns
3 September 2007
Citrus juices: "superior nutrient density"
14 May 2007
Drug prices lowered in French measures
13 February 2006
Bioniche's Betac found safe after recall
18 July 2005
Vits E and C shown to be safe at high dose
30 May 2005
Compound in apples could help fight AD
13 December 2004
Tokyo pharma stocks - week to September 27
4 October 2004
Lutein supps show promise in AMD
26 April 2004
India cuts 34 import-content bulk Rx prices
8 March 2004
Vit C and E linked to reduction in AD risk
16 February 2004
Vitamin C lowers risk of stroke in smokers
19 January 2004
India revises 22 bulk drug prices
2 June 2003
French generics sales up on govt/doc deal
15 July 2002
Zithromax "no efficacy in acute bronchitis"
20 May 2002
Chinoin eyeing-up stake in Pharmavit
25 February 2002
Stroke prevention emerges from heart disease
10 January 2001
Egyptian drugmakers' anger over pricing
15 May 2000
Merck KGaA fined in Canada over vitamin price-fixing
7 April 2000
Dumping causes key Indian bulk drug prices to plunge
12 November 1999
Chinese news
13 May 1999
Progenics gains dehydroascorbate license
29 March 1999
China: drug supply curbs start to bite
8 February 1999
Rhone-Poulenc Rorer Cuts More Jobs
25 June 1998
Gloom For Chinese Listed Drug Firms
16 June 1998
Roche Invests L120 Million In Scottish Vitamin C Plant
28 January 1998
Zila Acquires Oxycal Labs
13 November 1997
Foreign Companies Expand Chinese Operations
17 September 1997
Out-Of-Favor Drug Shows Promise In Restenosis
4 September 1997
First Half Profit Growth At Roche
20 August 1997
Boots Healthcare Holland Sells Roter Products
21 April 1997
First-Quarter Sales At Roche Up 18%
21 April 1997
Russian Drug Output Fails To Meet Demand
27 January 1997
Cautious Merck KGaA
2 December 1996
Roche To Produce Drugs And Vitamins In Shanghai
21 October 1996
Roche Moves To Increase OTC Stake In USA
8 July 1996
Volume Growth Boosts B-MS' First Quarter
6 May 1996
**Late News **Merck KGaA Acquires Seven Seas
6 May 1996
China Denies Block On Drug Investment
22 April 1996
French Pharmacists' Strength In Numbers
8 April 1996
Pharmavit A Springboard For B-MS Into E Europe
26 February 1996
Pharmavit Reports Flat 1995 Results
19 February 1996
Vitamin C "A Drug," Say French Courts
5 February 1996
China: Fermentation, Antibiotics And The Need To Modernize
27 November 1995
Greece: "Dangerous" Products' Use Grows
31 July 1995
Shanghai Plans Pharma Trade Boost
13 March 1995
Strong Demand For Hungarian Pharma Stocks
22 August 1994
VITAMIN C AND CIGARETTE SMOKE
8 August 1994
B-MS To Absorb France's UPSA
25 July 1994
UPSA TO CONSTUCT NEW PLANT
11 July 1994
FLUVOXAMINE AND IMPOTENCE
30 May 1994
SWISS PROVIDER OF CHINESE SCIENCE MARKET DATA
23 May 1994
US FDA VITAMINS REGS THIS WEEK
13 December 1993
NUTRITION LABELING AND EDUCATION IN THE USA
25 October 1993
NEW TRIAL SET FOR HYPOLIPEMICS
6 September 1993
MERCK AG AN OVERVIEW OF 1992 PERFORMANCE
19 July 1993
CUBAN PHARMA INDUSTRY SUCCESS
7 June 1993
WAYWARD ADVERTISING OF PRODUCTS IN FRANCE
5 April 1993
R-P RORER STRENGTHENS OTC
29 June 1992
FRENCH DOCTORS ATTACK COST DEAL
16 March 1992
US GOVT "CONCERN" OVER JAPANESE REG MOVES
9 March 1992
FRENCH PHARMACY MONOPOLY ROW
9 March 1992
ELDERLY HEALTH CARE: JAPAN'S SITUATION
3 February 1992
Showing 1-73 of 73 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
